Skip to main content

Ajmer

academics

 

Clinical research courses

  • Working opportunity as Business officer [MR] in Bayer Zydus Pharma

    Bayer Is a Multinational Company Based at Germany Having Operations In more than 117 Countries. and Specially Known for its Research Products Vacany is at Ajmer and Jaipur in Cardiac and Diabetic Division.

    Post: Business officer [MR]

  • Government vacancies for Pharmacists (54 Posts) in CRPF | All India level

    Applications are invited from male/female Indian citizens to fill up the following posts of Group “B” and “C” non ministerial, non gazetted, combatised paramedical staff in CRPF on all India basis. The posts are temporary but likely to become permanent.

    Post: Assistant Sub-Inspector (Pharmacists)

  • Career for M.Pharm as Project Fellow at Central University of Rajasthan

    The Central University of Rajasthan has been established by an Act of Parliament (Act No. 25 of 2009, The Gazette of India, No. 27, published on 20th March, 2009 as a new Central University, and is fully funded by the Government of India. The President of India, His Excellency Shri Pranab Mukherjee, is the Visitor of the Central University of Rajasthan.

  • Job for Female Compounder (pharmacist) at Regional Institute of Education

    The National Council of Educational Research and Training (NCERT) was established in 1961 by the Ministry of Education, Government of India to prepare quality teachers in Science, Humanities, Commerce, Agriculture and Technology. Consequently, four Regional Colleges of Education at Ajmer, Bhopal, Bhubaneswar and Mysore were established as constituents units of NCERT. Regional College of Education, Ajmer was set up in the year 1963. Later it was renamed as Regional Institute of Education (RIE), Ajmer in the year 1995.

    Post: Female Compounder

  • State Health Committee invites applications from Pharmacists | 141 Openings

    Applications are invited from eligible candidates for post of Pharmacist in given districts under national health mission.

    Post: Pharmacist

  • Advertisement for Junior Research Fellow in CUR | M.Pharm

    Applications are invited for the post of Junior Research Fellow on purely temporary basis to work on the DST-sponsored research project to be undertaken at the Department of Pharmacy, Central University of Rajasthan.

    Post: Junior Research Fellow (JRF) - 01

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • Vacancies for Pharmacists (168 posts) in RRB - Government of India

    Online applications are invited from eligible Indian Nationals for the following different Para-Medical Categories. Applications complete in all respects should be submitted only ONLINE to the concerned Railway Recruitment Board, as mentioned in Para-15 of General Instructions, till 23.59 Hrs of closing date.

    Post: Pharmacist - IIII

  • Work as Medical Representative in Viva Consultancy Services | 50 Vacancies

    Pharma company with OTC products sales having more than 8 years of market pretense across India

    Post: Medical Representative

Subscribe to Ajmer